Wait…Does the Bladder Have a Microbiome?
For decades, medical textbooks taught that healthy urine was sterile.
We now know that’s not quite true.
Advances in DNA sequencing and enhanced culture techniques have revealed that the urinary tract contains its own community of microorganisms, known as the urinary microbiome or urobiome.¹,²
Like the gut and vaginal microbiomes, this ecosystem can include many different types of bacteria. Researchers are now investigating whether changes within these microbial communities could influence urinary health and conditions such as interstitial cystitis/bladder pain syndrome (IC/BPS).¹
A major 2026 review published in Nature Reviews Urology highlighted growing evidence that urinary microbes may interact with the bladder lining, immune system, and nervous system in ways that could influence urgency, pain, and even treatment response.¹
So could the bacteria living in your bladder actually affect your IC symptoms?
The answer isn’t completely clear yet, but the research is getting increasingly interesting.
What Is the Urinary Microbiome?
The urinary microbiome refers to the collection of microorganisms that live within the urinary tract.¹,²
This discovery challenged the long-standing idea that bacteria in urine automatically indicated infection.
Using more sensitive techniques such as 16S ribosomal RNA sequencing and expanded quantitative urine culture, researchers have detected bacterial communities in people without urinary tract infections.²,³
Common urinary bacteria can include species belonging to genera such as:
- Lactobacillus
- Streptococcus
- Corynebacterium
- Gardnerella
- Escherichia
- Aerococcus¹⁻³
Importantly, the presence of bacteria does not automatically mean you have a UTI. The urinary microbiome represents a community of organisms that may normally live within the urinary tract.¹,²
The bigger question researchers are now asking is whether the balance and function of those microbes influence bladder health.
What Does the Urinary Microbiome Have to Do With IC?
IC/BPS is a chronic condition characterized by bladder-related pain, pressure, or discomfort, often accompanied by urinary urgency and frequency.⁷
Its underlying biology is complex and likely involves multiple interacting factors rather than one single cause. Researchers have investigated changes involving the bladder lining, immune activity, inflammation, nerve signalling, and pain processing.¹,⁶
The urinary microbiome has now become another piece of that puzzle.
Studies comparing people with IC/BPS with unaffected individuals have identified differences in urinary bacterial communities, although the results haven’t always been consistent.³⁻⁵
For example, one study found that women with IC had lower microbial diversity, fewer detectable Lactobacillus species, and higher levels of certain inflammatory markers compared with controls.⁴
Other studies, however, have found much smaller differences or no major overall difference in microbial composition between people with IC/BPS and healthy controls.³,⁵
More recent research suggests the picture may therefore be more nuanced than simply having “good” versus “bad” bladder bacteria.¹
There Probably Isn’t One “IC Microbiome”
This is one of the most important developments in the research.
Scientists have not identified one specific bacterium or microbial signature that causes IC/BPS.¹,³,⁵
A large study from the MAPP Research Network found that overall bacterial composition did not significantly differ between participants with IC/BPS and healthy controls, although differences involving specific bacteria were observed.⁵
Similarly, newer research published in 2026 did not find widespread microbiome differences associated with IC/BPS pain severity. Instead, researchers identified more subtle changes involving specific bacterial sequences and symptom patterns.⁸
This supports an emerging idea: the microbiome may influence IC through what microbes are doing, rather than simply which bacteria are present.
That’s where things get especially interesting.
How Could Bladder Bacteria Influence IC Symptoms?
Researchers are beginning to explore several possible pathways.
1. The Urinary Microbiome May Interact With Inflammation
Microorganisms constantly interact with the immune system.
Research in women with IC has identified both alterations in urinary microbial communities and differences in inflammatory signalling. One study found higher levels of certain inflammatory cytokines among participants with IC, with some inflammatory markers also correlating with symptom severity.⁴
Researchers are now investigating whether microbial activity could influence the bladder’s local immune environment and contribute to inflammation in susceptible individuals.¹,⁴
Importantly, we don’t yet know whether microbiome changes contribute to inflammation or whether inflammation changes the microbiome. That relationship is still being investigated.¹
2. Microbial Metabolites May Affect the Bladder
Bacteria don’t simply live in the body. They also produce metabolites, small compounds created as microorganisms process nutrients and interact with their environment.
A 2023 study combining microbiome and metabolomic analysis identified differences in both urinary microbes and metabolites among people with IC/BPS.⁶
This has led researchers to investigate whether microbial metabolites could interact with the bladder lining, immune system, or sensory nerves involved in pain and urgency.¹,⁶
The latest research suggests these microbial functions may ultimately tell us more about IC than simply identifying which bacterial species are present.¹
3. Bladder Bacteria May Communicate With Nerves
IC symptoms aren’t only about the bladder itself.
Pain and urgency involve communication between the bladder, peripheral nerves, spinal cord, and brain.¹
Emerging research suggests microbial metabolites and immune signalling may influence sensory nerves within the bladder, potentially affecting how strongly sensations such as bladder filling, urgency, or pain are perceived.¹
This creates an intriguing connection between the microbiome and the brain-bladder axis.
Researchers have even proposed a broader gut-bladder-brain network, in which the gut, vaginal, and urinary microbiomes may interact with immune, metabolic, and neural pathways involved in bladder function.¹
What About Lactobacillus?
If you’ve read about vaginal or gut health, you’re probably familiar with Lactobacillus.
Several studies have investigated whether certain Lactobacillus species may also play a beneficial role within the urinary microbiome.¹,⁴
In one study, the presence of Lactobacillus acidophilus was associated with less severe IC symptom and pain scores.⁴
The 2026 Nature Reviews Urology review similarly noted that Lactobacillus-predominant urinary microbiomes have been associated with lower symptom burden in some lower urinary tract conditions.¹
However, this doesn’t mean that more Lactobacillus automatically equals fewer IC symptoms. Different species may behave differently, and studies of IC/BPS have produced inconsistent results.¹,⁵
What the findings do suggest is that specific microbial communities and their functions may eventually help researchers better understand why symptoms differ so much between individuals.
Could the Gut and Vaginal Microbiomes Matter Too?
Possibly.
The urinary microbiome doesn’t exist in isolation.
Researchers are increasingly investigating interactions between the urinary, vaginal, and gut microbiomes, particularly in women.¹,²
A pilot study comparing premenopausal women with IC/BPS with unaffected controls found differences involving both urinary and vaginal microbial communities, suggesting that looking at the entire genitourinary ecosystem may provide more information than studying urine alone.²
The gut microbiome may also influence bladder health indirectly through immune regulation, microbial metabolites, and communication along the gut-brain axis.¹
This broader gut-vagina-bladder-brain connection is still emerging, but it could eventually help explain why bladder symptoms are influenced by such a wide range of factors.
Should You Take Probiotics for IC?
This is where it’s important not to get ahead of the science.
The microbiome is an exciting and evolving area of IC research, with growing evidence suggesting that microbial changes may be associated with IC/BPS. However, we do not yet know whether specific probiotic strains can improve IC/BPS symptoms or which strains may be most beneficial. More research is needed before targeted probiotic recommendations can be made.¹
We don’t yet know exactly what an “ideal” urinary microbiome looks like for every person, and simply taking a general probiotic doesn’t guarantee that those microorganisms will meaningfully alter the bladder microbiome.
However, researchers are actively investigating whether strategies such as probiotics, dietary modification, and other microbiome-targeted approaches could eventually complement conventional IC treatment.¹
Could the Urinary Microbiome Change How IC Is Treated?
This may be one of the most exciting possibilities.
IC/BPS is highly individual. Two people can have the same diagnosis while experiencing very different symptoms, triggers, and treatment responses.⁷
Researchers are investigating whether urinary microbiome profiling could eventually help identify different IC subgroups or predict which treatments are most likely to work for a particular person.¹
Future approaches could potentially combine information about:
- Urinary bacteria
- Microbial metabolites
- Inflammatory markers
- Bladder lining function
- Pain and nerve signalling
- Individual symptom patterns¹,⁶
Rather than treating every case of IC exactly the same way, these insights could contribute to a more personalized approach to bladder health.
The Bottom Line: Your Bladder Bacteria May Be Part of the IC Puzzle
The discovery of the urinary microbiome has changed the way researchers think about bladder health.
We now know that the urinary tract contains communities of microorganisms and that these microbes may interact with the bladder lining, immune system, inflammation, microbial metabolites, and sensory nerves involved in bladder function.¹,⁴,⁶
In IC/BPS, researchers have identified intriguing microbial differences, but there is no single “IC bacteria” or microbiome pattern that explains the condition.¹,³,⁵
Instead, the latest science points toward something more complex: **the way microbes interact with the rest of the body may matter just as much as which microbes are present.**¹
That opens the door to exciting possibilities.
As researchers learn more about the urinary microbiome and its connections with the gut, vagina, immune system, and brain-bladder axis, we may gain a better understanding of why IC symptoms vary so dramatically between individuals and, eventually, how treatment can become more personalized.
For now, the urinary microbiome represents a fascinating new piece of the IC puzzle and one that researchers are only beginning to understand.
Frequently Asked Questions
Does your bladder have bacteria?
Yes. Modern DNA sequencing and enhanced culture techniques have shown that healthy urinary tracts contain communities of microorganisms collectively known as the urinary microbiome or urobiome.¹,²
Is interstitial cystitis caused by bacteria?
Current evidence has not identified a single bacterium or microbial signature that causes IC/BPS. Researchers are instead investigating whether changes in microbial communities and their interactions with immune and nervous system pathways may contribute to symptoms in some individuals.¹,³,⁵
Is IC the same as a UTI?
No. IC/BPS and urinary tract infections can cause overlapping symptoms, such as urgency, frequency, and bladder discomfort, but they are different conditions. IC/BPS is a chronic bladder pain condition and is not currently defined as an active bacterial infection.⁷
Can probiotics help interstitial cystitis?
Researchers are interested in probiotics and other microbiome-targeted approaches, but there is not yet enough clinical evidence to recommend a specific probiotic strain as an established treatment for IC/BPS.¹
What is the gut-bladder-brain axis?
The gut-bladder-brain axis is an emerging concept describing potential communication between microbial communities, the immune system, metabolic pathways, nerves, and the brain. Researchers are investigating whether these interconnected systems may influence bladder sensation, urgency, and pain.¹
References
- Spazzapan M, Raison N, Steves C, et al. The urinary microbiome, overactive bladder and bladder pain syndrome/interstitial cystitis: mechanisms, diagnostics and therapeutic opportunities. Nat Rev Urol. Published online July 27, 2026. doi:10.1038/s41585-026-01174-3.
- Meriwether KV, Lei Z, Singh R, et al. The vaginal and urinary microbiomes in premenopausal women with interstitial cystitis/bladder pain syndrome as compared to unaffected controls: a pilot cross-sectional study. Front Cell Infect Microbiol. 2019;9:92. doi:10.3389/fcimb.2019.00092.
- Bresler L, Price TK, Hilt EE, et al. Female lower urinary tract microbiota do not associate with IC/PBS symptoms: a case-controlled study. Int Urogynecol J. 2019;30(11):1835-1842.
- Abernethy MG, Rosenfeld A, White JR, Mueller MG, Lewicky-Gaupp C, Kenton K. Urinary microbiome and cytokine levels in women with interstitial cystitis. Obstet Gynecol. 2017;129(3):500-506. doi:10.1097/AOG.0000000000001892.
- Nickel JC, Stephens A, Landis JR, et al. A culture-independent analysis of the microbiota of female interstitial cystitis/bladder pain syndrome participants in the MAPP Research Network. J Clin Med. 2019;8(3):415. doi:10.3390/jcm8030415.
- Xu H, et al. Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis/bladder pain syndrome patients. J Transl Med. 2023.
- Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022;208(1):34-42. doi:10.1097/JU.0000000000002756.
- Ackerman AL, et al. Urobiome analysis in interstitial cystitis/bladder pain syndrome reveals nuanced differences associated with localized pain. Published 2026.